
Pharma Pulse 5/29/24: The Impact of Wearables in Clinical Research,Prospects for Comprehensive PBM Reform & more
The latest news for pharma industry insiders.
Jeremy Wyatt, CEO of ActiGraph, discusses how these devices are changing patient monitoring in clinical trials.
Paul Kelly, of Capitol Advocacy & Government Affairs, LLC , and a veteran Washington, D.C., lobbyist, sees some obstacles to the Senate passig a comprehensive PBM bill.
Move comes after firm became embroiled in a legal battle over a new voice assistant in its latest artificial-intelligence model.
Conceive, Evernow, FitOn, Nurx, Cove, and Nutrium Join as Founding Members to Support the Coalition’s Focus on Expanding Access to Women-Centered Healthcare Resources in the Workplace.
About the opportunities for #ai in #pharma and why #israelinnovation🇮🇱 is poised to play a role in Pharmaceutical Executive
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
